By 2032, the personalized medicine market Share is expected to be worth USD 970.7 billion, growing at a CAGR of 7.20%. The global demand for novel drugs to treat the rising incidence of cancer and other diseases is one of the factors driving the market for personalized medicine. Companion diagnostics, a crucial element of personalized medicine, also identifies patients who will likely...